Richard Warburg

Richard Warburg

Nessuna posizione attualmente

Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Richard Warburg is a recognized authority on successful strategies for advancing pharmaceuticals and related matters, including working with companies such as ADC Therapeutics, Sugen, Plexxikon, and Afferant and being a key player in the DNA sequencing litigation over SEQUENASE DNA polymerase.
He has been involved in the successful advancement of many pharmaceuticals from preclinical to clinical and beyond.
He is a General Partner of Scientia Ventures since its inception.
Previously, he was the Managing Director, Intellectual Property and Licensing, for Auven Therapeutics Management LLLP.
Additionally, Dr. Warburg is the owner and founder of Godney Holdings, LLC, an IP consulting and management firm based out of St Thomas, US Virgin Islands.
Dr. Warburg was a partner at the law firms of Foley & Lardner LLP and Lyon & Lyon, and a law clerk with Fish & Richardson.
Dr. Warburg has over 30 years’ experience in intellectual property litigation, strategic counseling, licensing and patent prosecution.
Dr. Warburg has significant appellate, litigation, interference and worldwide prosecution and opposition experience in most technical areas including bio pharmacology, proteomics, antisense, and diagnostic devices.
Dr. Warburg is registered to practice before the U.S.
Patent and Trademark office.
He is admitted to practice in California and Massachusetts.
Dr. Warburg is a graduate of Birmingham University, England, where he received his Bachelor of Science degree in 1978 and his Ph.D.
in molecular biology in 1981.
After a post-doctoral fellowship at Brandeis University, acting as an adjunct professor at Wellesley College, and an instructor at University of Massachusetts, he attended Suffolk University law school and graduated valedictorian magna cum laude in 1990.
Dr. Warburg is the inventor on world-wide patents for a micro-centrifuge tube opening device, the inventor of the PATENTIAL board game concerning the biotech business model.

Posizioni attive di Richard Warburg

SocietàPosizioneInizio
Direttore/Membro del Consiglio 01/01/2018
Direttore/Membro del Consiglio 01/08/2019
Direttore/Membro del Consiglio 01/01/2018
Direttore/Membro del Consiglio -
Investitore di Private Equity 01/01/2016
Direttore/Membro del Consiglio 01/01/2019
Direttore/Membro del Consiglio 01/01/2018
Tutte le posizioni attive di Richard Warburg

Precedenti posizioni note di Richard Warburg

SocietàPosizioneFine
Investitore di Private Equity 01/10/2019
Corporate Officer/Principal 01/01/2010
░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Richard Warburg

Formazione di Richard Warburg

University of Birmingham Doctorate Degree
Suffolk University Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Richard Warburg

Relazioni

100 +

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
ADC THERAPEUTICS SA

Health Technology

Aziende private12

Commercial Services

Commercial Services

Commercial Services

Health Technology

Technology Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Richard Warburg